Subscribe to Newsletter

Diabetes

Business & Profession Cataract

The Write Stuff

| Andrew Lam | 9 min read

Subspecialties Glaucoma

The Mindset Shift

| 3 min read

If the drop first regimen isn’t working – what comes next?
Subspecialties Basic & Translational Research

Recycling for ROP

| Alun Evans, Jamie Irvine | 2 min read

K604 offer potential new treatment for ROP
Subspecialties Health Economics and Policy

Hawk-Eyed Focus

| Sean Rodriguez, Zachary Mortenson | 8 min read

Fighting health disparities in ophthalmology
Subspecialties Retina

Wide Field, Deep Learning

| Pr. Eric Souied | 5 min read

How AI-assisted UWF imaging is being used to classify retinal vascular diseases
Subspecialties Retina

Eye Sp.Eye Innovation

| Jon Greenaway | 6 min read

How the Sp.Eye system makes intravitreal more efficient for doctors and safer and less stressful for patients
Subspecialties Retina

DR Snapshot

| Sarah Healey | 2 min read

Diabetic retinopathy poses a large global threat to patients and the economy
Subspecialties Diabetes

The Sweet Spot

| Akrit Sodhi | 5 min read

The links between low blood sugar and diabetic eye disease
Business & Profession Retina

Lowering Lipids – and AMD

| Sarah Healey | 2 min read

Systemic lipid-lowering and antidiabetic medications have been found to lower AMD prevalence
Business & Profession Business and Innovation

In Agreement

| Sponsored by PolyPhotonix

PolyPhotonix names Prevail Partners as its lead US investor whose affiliate will lead Noctura 400 FDA clinical trials
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

December Issue of The Ophthalmologist
Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: